As demonstrated by the association analysis between spontaneous IDO2-specific T-cell responses and the IDO2 genotype of melanoma, renal cell carcinoma, and breast cancer patients, the induction of IDO2-specific T cells in peripheral blood is restricted to individuals that are not homozygous for the stop codon [79]. The gene discussed is IDO2; the disease is breast carcinoma.